ArticleNeural regeneration research2026

Neuroinflammation and noradrenergic modulation with β2-adrenoceptors: Emerging therapeutic targets for Parkinson's diseases.

Maria Micaelle Gomes Tavares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.